IRIS
TONINI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 20.529
NA - Nord America 4.593
EU - Europa 1.964
SA - Sud America 1.301
AF - Africa 141
OC - Oceania 61
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 2
Totale 28.595
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 14.696
US - Stati Uniti d'America 4.342
CN - Cina 2.449
HK - Hong Kong 2.249
BR - Brasile 981
GB - Regno Unito 632
VN - Vietnam 620
IT - Italia 411
DE - Germania 275
IN - India 150
AR - Argentina 140
CA - Canada 136
NL - Olanda 103
FI - Finlandia 82
ID - Indonesia 78
MX - Messico 78
ZA - Sudafrica 73
AU - Australia 54
EC - Ecuador 53
JP - Giappone 50
TR - Turchia 50
UA - Ucraina 50
ES - Italia 48
PL - Polonia 46
FR - Francia 45
BD - Bangladesh 39
CZ - Repubblica Ceca 36
RU - Federazione Russa 33
CO - Colombia 31
PY - Paraguay 27
SE - Svezia 27
EE - Estonia 24
PE - Perù 23
CH - Svizzera 21
CL - Cile 19
LT - Lituania 17
BG - Bulgaria 16
BE - Belgio 15
VE - Venezuela 15
AT - Austria 14
IQ - Iraq 13
KR - Corea 13
TW - Taiwan 12
EG - Egitto 11
UZ - Uzbekistan 11
IL - Israele 10
MA - Marocco 10
RO - Romania 9
SA - Arabia Saudita 9
UY - Uruguay 8
DO - Repubblica Dominicana 7
PH - Filippine 7
SI - Slovenia 7
TH - Thailandia 7
TN - Tunisia 7
AZ - Azerbaigian 6
BA - Bosnia-Erzegovina 6
DZ - Algeria 6
HU - Ungheria 6
PK - Pakistan 6
BY - Bielorussia 5
IE - Irlanda 5
IR - Iran 5
JO - Giordania 5
KW - Kuwait 5
KZ - Kazakistan 5
PT - Portogallo 5
AL - Albania 4
DM - Dominica 4
GT - Guatemala 4
NZ - Nuova Zelanda 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
CI - Costa d'Avorio 3
CY - Cipro 3
ET - Etiopia 3
KH - Cambogia 3
LB - Libano 3
ML - Mali 3
NI - Nicaragua 3
NO - Norvegia 3
PA - Panama 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AQ - Antartide 2
BB - Barbados 2
BF - Burkina Faso 2
BO - Bolivia 2
CR - Costa Rica 2
CU - Cuba 2
FK - Isole Falkland (Malvinas) 2
GA - Gabon 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
KE - Kenya 2
LU - Lussemburgo 2
MK - Macedonia 2
Totale 28.545
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.234
Singapore 1.612
Hefei 1.202
Ashburn 1.133
Boardman 703
London 555
Dallas 457
Beijing 409
Shanghai 406
Ho Chi Minh City 240
Los Angeles 151
San Francisco 138
Council Bluffs 134
Munich 134
Hanoi 118
São Paulo 112
Pune 85
Seattle 84
Rome 78
Toronto 78
Santa Clara 67
New York 65
Amsterdam 62
Washington 62
Turku 50
Rio de Janeiro 45
Johannesburg 43
Warsaw 43
Mexico City 41
Tokyo 39
Brno 34
Brooklyn 33
Montreal 32
Helsinki 31
Melbourne 31
Chicago 30
Milan 28
Da Nang 27
Chennai 25
Thái Bình 23
Boston 22
Naples 22
Stockholm 22
Buenos Aires 21
Guayaquil 21
Biên Hòa 19
Belo Horizonte 18
Haiphong 18
Atlanta 16
Phoenix 16
Secaucus 16
Asunción 15
Quito 15
Boydton 14
Brasília 14
Porto Alegre 14
West Jordan 14
Ankara 13
Burgas 13
Hanover 13
Lima 13
Canberra 12
Charlotte 12
Curitiba 12
Denver 12
Hasselt 12
Manchester 12
Poplar 12
Ribeirão Preto 12
St Louis 12
Hải Dương 11
Jakarta 11
Manaus 11
Ninh Bình 11
Sydney 11
Tashkent 11
Thái Nguyên 11
Can Tho 10
Fortaleza 10
Guangzhou 10
Padova 10
Phủ Lý 10
Salvador 10
Sona 10
Lấp Vò 9
Maceió 9
Osasco 9
San Jose 9
The Dalles 9
Campinas 8
Caxias do Sul 8
Central 8
Frankfurt am Main 8
Haikou 8
Jinan 8
Las Vegas 8
Redmond 8
Xi'an 8
Buffalo 7
Bắc Giang 7
Totale 11.609
Salva come PNG Salva come JPEG
Nome #
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 252
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 233
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 229
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 222
A novel predictive biomarker of immunotherapy response in metastatic renal cell carcinoma (mRCC): The lymphocyte microRNA expression profile. 219
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 213
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 213
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 212
5-Fluorouracil, epirubicin, and BCNU (FEB) in advanced measurable gastric cancer 211
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 210
Early impairment of food intake in patients newly diagnosed with cancer 207
Chondrosarcoma of the iliac wing in Von Hippel-Lindau disease 207
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 207
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 204
Complementary use of local excision and transanal endoscopic microsurgery for rectal cancer after neoadjuvant chemoradiation 204
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 202
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 202
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 199
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 199
Premetastatic niche: ready for new therapeutic interventions? 198
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 197
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 197
In Situ Identification of CD44+/CD24− cancer cells in primary human breast carcinomas 196
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 195
COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification 194
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 192
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study 192
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 189
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma 188
Prevention of radiotherapy-induced emesis 188
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 187
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 187
[Methodological issues and first results of a record linkage between AIDS and Cancer Registries in Italy 187
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 186
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 186
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 183
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 180
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 180
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 178
A staphylococcus aureus coinfection on a COVID-19 pneumonia in a breast cancer patient 175
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 175
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 174
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 171
Docetaxel induced pericardial effusion 170
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 158
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 144
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 129
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 128
A giant sarcoma of the parotid gland: A case report and review of the literature 121
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 118
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 118
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 116
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 113
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 113
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 112
A pathology-based combined model to identify pam50 non-luminal intrinsic disease in hormone receptor-positive HER2-negative breast cancer 110
A close relationship between HIF-1α expression and bone metastases in advanced NSCLC, a retrospective analysis 108
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 108
'Old' and 'new' drugs for the treatment of cancer pain 108
Colorectal carcinomas and PTEN/MMAC1 gene mutations 106
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 105
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 104
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 102
Biological effects of cabozantinib on bone microenvironment 102
A Longitudinal Study of Breakthrough Cancer Pain: An Extension of IOPS-MS Study 102
[Neoplastic hypercalcemia]. 101
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer 100
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 100
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 99
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 98
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 98
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 98
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 98
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 97
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 97
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 96
A form to report pain assessment and monitoring in the oncology clinical record: a Delphi process 96
Cerebellar metastasis from pancreatic adenocarcinoma. A case report 96
Idiosyncratic reaction after oxaliplatin infusion 96
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 96
Azygo-tracheal fistula in a complete implantable central venous system 96
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 96
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 96
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 96
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 95
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 95
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 95
Brain microischemic phenomena in a woman receiving bevacizumab treatment: a case report 95
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 95
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 94
Atypical chronic head and neck pain: don't forget Eagle's syndrome 94
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 94
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 94
[Aztreonam and oxacillin in the treatment of febrile neutropenic patients with solid tumors]. 93
Liver involvement in the course of thymoma-associated multiorgan autoimmunity: The first histological description 93
An omental mass: any hypothesis? 92
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 92
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 92
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 90
[Fluorouracil and high-dose folinic acid in the treatment of advanced colorectal carcinoma]. 89
Totale 14.457
Salva come PNG Salva come JPEG
Categoria #
all - tutte 261.090
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 261.090
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022839 0 5 8 11 63 5 6 5 20 22 19 675
2022/2023202 22 7 3 19 9 8 18 18 12 1 76 9
2023/20242.026 46 228 137 146 186 872 21 131 26 67 78 88
2024/202519.040 311 224 781 138 150 472 324 79 1.660 1.529 6.204 7.168
2025/20266.642 1.669 739 1.263 2.160 674 137 0 0 0 0 0 0
Totale 28.749